Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

DNA Liquid Biopsies for Cancer-Associated Venous Thromboembolism Prediction

Blood (2023) 142 (Supplement 1): 569.

https://doi.org/10.1182/blood-2023-172820

Published: 2023

Journal Articles

Dynamic Modelling for Cancer-Associated Venous Thromboembolism

Simon Mantha, Rohan Singh, Jeffrey I. Zwicker

Blood (2023) 142 (Supplement 1): 566.

https://doi.org/10.1182/blood-2023-185010

Published: 2023

Journal Articles

Efficacy and Safety of Extended Use of Romiplostim Treatment for Chemotherapy-Induced Thrombocytopenia

Cy R Wilkins, Jocelyn Ortiz, Leah Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff

Blood (2021) 138 (Supplement 1): 2075.

https://doi.org/10.1182/blood-2021-145958

Published: 2021

Journal Articles

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Blood (2021) 137 (15): 2103–2113.

https://doi.org/10.1182/blood.2020007488

Published: 2021

Includes: Supplemental data

Journal Articles

Prediction of COVID-19 Mortality in Patients with Cancer

Simon Mantha, MDMPH, Justin Jee, Gerald A. Soff, MD, Melissa S. Pessin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138576

Published: 2020

Journal Articles

Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141882

Published: 2020

Journal Articles

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Claire M Sathe, MD, Chester Poon, Debra M. M Sarasohn, MD, Leah Gilbert, Alok A Khorana, MD, Simon Mantha, MDMPH, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-142037

Published: 2020

Journal Articles

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Simon Mantha, MDMPH, Andrew Dunbar, MD, Kelly L. Bolton, MD PhD, Sean Devlin, PhD, Dmitriy Gorenshteyn, PhD, Mark Donoghue, PhD, Maria E. Arcila, MD, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-138579

Published: 2020

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

Journal Articles

Hypofibrinogenemia and Disseminated Intravascular Coagulation Rarely Complicate Treatment-Naive Acute Lymphoblastic Leukemia

Charles Gaulin, MBBS, Angela Chan, MSN, AGPCNP-BC, Mark Blaine Geyer, MD, Jae H. Park, MD, Simon Mantha, MDMPH, Martin S. Tallman, MD

Blood (2018) 132 (Supplement 1): 1217.

https://doi.org/10.1182/blood-2018-99-110741

Published: 2018

Journal Articles

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Gerald A. Soff, MD, Yimei Miao, BS, Sean M. Devlin, PhD, Simon Mantha, MD MPH, Jodi V Mones, MD, Valery J Li, MD, Ghassan K Abou-Alfa, MD MBA, Andrea Cercek, MD, Nancy Kemeny, MD, Rekha Parameswaran, MD

Blood (2017) 130 (Supplement 1): 289.

https://doi.org/10.1182/blood.V130.Suppl_1.289.289

Published: 2017

Journal Articles

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Blood (2017) 129 (13): 1763–1767.

https://doi.org/10.1182/blood-2016-10-747170

Published: 2017

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Simon Mantha, MD MPH, Gerald A. Soff, MD

Blood (2016) 128 (22): 2619.

https://doi.org/10.1182/blood.V128.22.2619.2619

Published: 2016

Journal Articles

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Eva Simona Laube, MD, Anthony Yu, MD, Dipti Gupta, MD MPH, Yimei Miao, BS, Patrick Samedy, MS, Jonathan Wills, BA, Stephen J. Harnicar, PharmD, BCOP, BCPS, Gerald A. Soff, MD, Simon Mantha, MD MPH

Blood (2016) 128 (22): 2621.

https://doi.org/10.1182/blood.V128.22.2621.2621

Published: 2016

Journal Articles

Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative

Simon Mantha, MD MPH, Yimei Miao, BS, Debra Sarasohn, MD, Jonathan Kessler, Rekha Parameswaran, MD, Samantha Stefanik, Gagandeep Brar, MD, Patrick Samedy, Jonathan Wills, Dhruvkumar Patel, Gerald A Soff, MD

Blood (2015) 126 (23): 431.

https://doi.org/10.1182/blood.V126.23.431.431

Published: 2015

Journal Articles

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

Yimei Miao, BS, Gerald A Soff, MD, Rekha Parameswaran, MD, Jonathan Wills, Simon Mantha, MD MPH

Blood (2015) 126 (23): 429.

https://doi.org/10.1182/blood.V126.23.429.429

Published: 2015

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Aiqi Dong, Sean Devlin, PhD, Simon Mantha, MD MPH, Rekha Parameswaran, MD, Gerald A Soff, MD

Blood (2015) 126 (23): 2068.

https://doi.org/10.1182/blood.V126.23.2068.2068

Published: 2015

Journal Articles

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Catherine C. Coombs, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Robert Siegelbaum, MD, Rekha Parameswaran, MD, Simon Mantha, MD MPH, Gerald A Soff, MD

Blood (2015) 126 (23): 1112.

https://doi.org/10.1182/blood.V126.23.1112.1112

Published: 2015

Journal Articles

Determinants of Fatal Bleeding during Induction Therapy for Acute Promyelocytic Leukemia in the ATRA Era

Simon Mantha, MD MPH, Debra Goldman, MS, Sean M. Devlin, PhD, Ju-Whei Lee, PhD, Diana Zannino, BSc, MSc, Dan Douer, MD, Harry J Iland, MBBS FRACP FRCPA, Mark R. Litzow, MD, Eytan M. Stein, Frederick Appelbaum, MD, Richard A. Larson, Jacob M. Rowe, MD, Martin S. Tallman, MD

Blood (2014) 124 (21): 948.

https://doi.org/10.1182/blood.V124.21.948.948

Published: 2014

Journal Articles

MLL Exons 4-8 Duplication in a Patient with Calr -Mutated Essential Thrombocythemia

Simon Mantha, MD MPH, Ross L. Levine, MD, Raajit K. Rampal, MD PhD

Blood (2014) 124 (21): 5583.

https://doi.org/10.1182/blood.V124.21.5583.5583

Published: 2014

NARROW

DNA Liquid Biopsies for Cancer-Associated Venous Thromboembolism Prediction

Dynamic Modelling for Cancer-Associated Venous Thromboembolism

Efficacy and Safety of Extended Use of Romiplostim Treatment for Chemotherapy-Induced Thrombocytopenia

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Prediction of COVID-19 Mortality in Patients with Cancer

Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Hypofibrinogenemia and Disseminated Intravascular Coagulation Rarely Complicate Treatment-Naive Acute Lymphoblastic Leukemia

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Determinants of Fatal Bleeding during Induction Therapy for Acute Promyelocytic Leukemia in the ATRA Era

MLL Exons 4-8 Duplication in a Patient with Calr -Mutated Essential Thrombocythemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only